Concord Biotech

Sector: Healthcare

Followers

0
0
0
0
.
9
9
0
0
1
1
,
1
1
-30.50 (-2.68%)

As on 02 Feb, 2026 | 15:56

Open Trading A/c
Day Range
1,100.00
1,149.80
LH
52 Week Range
1,100.00
2,451.70
LH
Volume
* i
Bid / Ask
64,935.00
0.00 / 0.00

Concord Biotech Announcements

Concord Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

06 Jan, 2026 | 10:54am • Source: NSE

Enclosed herewith the certificate under Regulation 74(5) of the SEBI (DP) Regulations,2018 for the quarter ended 31.12.2025

06 Jan, 2026 | 10:39am • Source: BSE

Intimation of Trading window closure from 1st January,2026

26 Dec, 2025 | 09:42am • Source: BSE

Ms. Hina Patel, has tendered her resignation from the post of Company Secretary and Compliance Officer w.e.f 21/01/2026 after close of working hours.

24 Dec, 2025 | 05:28pm • Source: BSE

Change in KMPs Authorization for determining materiality of Event and Information to the Stock Exchanges

18 Dec, 2025 | 01:50pm • Source: BSE

Appointment of Mr. Raviraj Karia as CFO and KMP of the company w.e.f. 18/12/2025

18 Dec, 2025 | 12:58pm • Source: BSE

Appointment of Mr. Raviraj Karia as Chief Financial Officer and KMP

18 Dec, 2025 | 12:54pm • Source: BSE

Concord Biotech Limited has informed the Exchange regarding Resignation of Mr Lalit Sethi as Chief Financial Officer of the company w.e.f. January 05, 2026

08 Dec, 2025 | 02:24pm • Source: NSE

Early Retirement of Chief Financial officer (KMP) w.e.f. closing of working business hours on January 05,2026

08 Dec, 2025 | 01:53pm • Source: BSE

Early retirement of Chief Financial Officer

08 Dec, 2025 | 01:51pm • Source: BSE

Transcript of Q2FY26 earning call held on November'' 14, 2025

19 Nov, 2025 | 10:19am • Source: BSE

Newspaper clippings of Q2 FY25-26

14 Nov, 2025 | 04:10pm • Source: BSE

Intimation of Successful Completion of NAFDAC Inspection at our Oral Solid Dosage Unit-2, facility located at Valthera

08 Oct, 2025 | 11:04am • Source: BSE

Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP) regulations, 2018 for the quarter ended 30.09.2025

06 Oct, 2025 | 05:16pm • Source: BSE

Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

25 Sep, 2025 | 10:07am • Source: NSE

Intimation of Trading Window Closure

25 Sep, 2025 | 10:02am • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 19th September, 2025 at 11:00...

11 Sep, 2025 | 03:18pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 17th September, 2025 at 10:00...

11 Sep, 2025 | 03:14pm • Source: BSE

Concord Biotech Limited has informed the Exchange about Schedule of meet

11 Sep, 2025 | 03:13pm • Source: NSE

Concord Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 09, 2025

11 Sep, 2025 | 03:08pm • Source: NSE